Upper urinary tract urothelial carcinoma patients show better overall response rate than bladder cancer patients during enfortumab vedotin treatment following pembrolizumab
在接受帕博利珠单抗治疗后,接受恩福妥单抗治疗的上尿路尿路上皮癌患者的总体缓解率优于膀胱癌患者。
期刊:Translational Andrology and Urology
影响因子:1.7
doi:10.21037/tau-2025-254
Hashimoto, Mamoru; Fukiage, Ken; Taniguchi, Kosei; Minami, Takafumi; Fukuokaya, Wataru; Mori, Keiichiro; Yanagisawa, Takafumi; Tsujino, Takuya; Maenosono, Ryoichi; Saruta, Masanobu; Takahara, Kiyoshi; Hashimoto, Takeshi; Hirasawa, Yosuke; Azuma, Haruhito; Ohno, Yoshio; Shiroki, Ryoichi; Fujita, Kazutoshi